Mycophenolate mofetil in dermatomyositis: is it safe?

Neurology
J RowinM N Meriggioli

Abstract

The authors report 10 patients with idiopathic dermatomyositis treated with mycophenolate mofetil in combination with corticosteroids. Successful steroid taper without disease relapse was achieved in six patients; however, in three patients, treatment was associated with opportunistic infections, leading to death in one patient. The disproportionately high rate of opportunistic infections in this group is considered.

Citations

Dec 1, 2006·Der Nervenarzt·Peter Rieckmann, Peter Rieckmann
Dec 15, 2010·Rheumatology International·Rawane DagherRolando Cimaz
Nov 14, 2008·Journal of Neurology·UNKNOWN Multiple Sclerosis Therapy Consensus Group (MSTCG)R Hohlfeld
Jun 12, 2013·American Journal of Clinical Dermatology·Alisa N FemiaJeffrey P Callen
Nov 21, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Heinz Wiendl
Nov 3, 2012·Seminars in Neurology·Mazen M Dimachkie, Richard J Barohn
Mar 1, 2012·Journal of Clinical Neuromuscular Disease·Nicholas ParzialeJayashri Srinivasan
Jul 16, 2010·Joint, Bone, Spine : Revue Du Rhumatisme·Anne TournadreMartin Soubrier
Jul 20, 2014·Neurologic Clinics·Mazen M DimachkieAnthony A Amato
Mar 3, 2011·Current Rheumatology Reports·Rohit Aggarwal, Chester V Oddis
Jul 9, 2008·Current Allergy and Asthma Reports·Jeffrey P Callen
Aug 28, 2015·Expert Review of Clinical Immunology·Siamak Moghadam-KiaChester V Oddis
May 2, 2009·Expert Opinion on Pharmacotherapy·Gerald J D HengstmanBaziel G M van Engelen
Oct 6, 2012·Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology·Takako Imai Tanaka, Shin-Mey Rose Y Geist
Jul 12, 2011·Autoimmunity Reviews·Isabelle Marie, Luc Mouthon
Nov 5, 2010·Seminars in Arthritis and Rheumatism·Isabelle MariePierre-Yves Hatron
Nov 26, 2010·Journal of Neuroimmunology·Mazen M Dimachkie
Apr 24, 2009·Autoimmunity Reviews·Maria Giovanna DanieliArmando Gabrielli
Dec 17, 2008·La Presse médicale·Isabelle Marie
Jan 20, 2009·Journal of the American Academy of Dermatology·Alissa K OrvisShannon W Watkins
Apr 22, 2008·Journal of the American Academy of Dermatology·Luciano J Iorizzo, Joseph L Jorizzo
Feb 10, 2007·Autoimmunity Reviews·Luca IaccarinoAndrea Doria
Nov 1, 2007·Dermatologic Therapy·Jeffrey Zwerner, David Fiorentino
Apr 9, 2008·Dermatologic Therapy·Bruce H Thiers
Jun 30, 2012·Dermatologic Therapy·Christina Lam, Ruth Ann Vleugels
Jun 4, 2010·Arthritis Care & Research·Kelly A Rouster-StevensLauren M Pachman
Sep 12, 2013·Arthritis and Rheumatism·Nicholas A YoungWael N Jarjour
Sep 13, 2006·Clinics in Dermatology·Jeffrey P Callen, Robert L Wortmann
Jun 26, 2013·American Journal of Therapeutics·Tanisha MathurJoel A Block
Jul 18, 2015·Zeitschrift für Rheumatologie·K M Rösler, O Scheidegger
Feb 22, 2011·La Presse médicale·Isabelle Marie
Apr 22, 2016·Journal of Internal Medicine·C V Oddis
Jan 11, 2007·Lupus·P F FinelliA Prasad
Mar 30, 2018·Nature Reviews. Rheumatology·Chester V Oddis, Rohit Aggarwal
Mar 19, 2013·The Journal of Rheumatology·Ilias N Lazarou, Pierre-André Guerne
Jun 2, 2015·European Respiratory Review : an Official Journal of the European Respiratory Society·Jean-Christophe LegaVincent Cottin
Jul 12, 2017·Expert Review of Clinical Pharmacology·Zoltán GrigerKatalin Dankó
Jan 19, 2019·Advances in Rheumatology·Pablo Arturo Olivo PalloSamuel Katsuyuki Shinjo
Feb 15, 2020·Nature Reviews. Rheumatology·Jasper C A Broen, Jacob M van Laar
Feb 26, 2020·American Journal of Clinical Dermatology·Gabriela A CobosRuth Ann Vleugels
Aug 28, 2020·Current Rheumatology Reports·Lauren N Smith, Julie J Paik

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.